
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAsure Methylation Test, a novel CE-marked molecular diagnostic test for use in differentiating patients’ risk of developing cervical cancer.

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAsure Methylation Test, a novel CE-marked molecular diagnostic test for use in differentiating patients’ risk of developing cervical cancer.

Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
Program Announcements:

The venture fund working to make sweetgreen and CustomInk into household names has raised more than half a billion dollars to double down on its strategy.

The BIO 2016 Global Cluster Hub brought together cluster managers and key players from across the globe, with unique insights into the arrival of digital health within their own communities, plus opportunities to build partnerships around specific aspects of digital health. CEBR members presented specific examples of digital health cluster support activities, alongside our global international cluster partners and we look forward to opening doors between clusters on the fastest moving sectoral development in the world.

Merck has added a month-long Silicon Valley stay to the pot on offer for start-ups participating in the next round of its accelerator programmes in Germany and Kenya. The programmes seek to support healthcare, life science and performance materials start-ups, with a particular focus on those developing digital solutions.

Rep. Steny Hoyer and other Democratic lawmakers plan to outline a broad strategy for expanding U.S. manufacturing in Baltimore on Monday, at a time when Washington has stalled on measures sought by the industry.

The Pentagon has made an unprecedented push to cozy up with Silicon Valley over the past two years, opening satellite offices on the West Coast and Boston in an effort to import fresh insight, ideas and innovation from the private sector to the military.

Digital health technology leader WellDoc® today announced results from a real-world study designed to evaluate the feasibility and reach of using a lay coach in conjunction with BlueStar® mobile prescription therapy to provide ongoing self-management support for people living with type 2 diabetes in a primary care setting. The data were featured via a poster presented today at the American Diabetes Association’s (ADA) 76th Scientific Sessions, taking place now at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

Omicia has raised $23 million from Roche’s ($RHHBY) venture fund and other investors. The Series B round will support the expansion of Omicia’s NGS interpretation and reporting capabilities into new sectors, including clinical trials and life science research.

Governor Terry McAuliffe announced today $3.4 million in funding to support 48 Commonwealth Research Commercialization Fund (CRCF) awards representing targeted areas of promising research commercialization, including cybersecurity, energy, data analytics, unmanned systems and life sciences.